The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday: ** Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.** Roche Holding AG has agreed to purchase U.S. biotech company InterMune Inc for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.43% or $0.71/share to $166.27. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2778860 shares of AGN exchange hands on a given day and today's volume is recorded at 66274.
InterMune, Inc. (InterMune) is a biotechnology company focused on the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases. Shares of ITMN traded higher by 35.87% or $19.3/share to $73.10. In the past year, the shares have traded as low as $10.95 and as high as $55.24. On average, 2075640 shares of ITMN exchange hands on a given day and today's volume is recorded at 14317377.
Source
